XW014
/ Sciwind Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
September 20, 2025
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
(clinicaltrials.gov)
- P1 | N=127 | Completed | Sponsor: Sciwind Biosciences USA Co., Ltd. | Trial completion date: Mar 2025 ➔ Nov 2024 | Active, not recruiting ➔ Completed
Trial completion • Trial completion date • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
December 26, 2024
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
(clinicaltrials.gov)
- P1 | N=152 | Active, not recruiting | Sponsor: Sciwind Biosciences USA Co., Ltd. | Recruiting ➔ Active, not recruiting
Enrollment closed • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
June 06, 2024
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
(clinicaltrials.gov)
- P1 | N=152 | Recruiting | Sponsor: Sciwind Biosciences USA Co., Ltd. | N=104 ➔ 152 | Trial completion date: Aug 2024 ➔ Mar 2025 | Trial primary completion date: Jan 2024 ➔ Feb 2025
Enrollment change • Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
October 13, 2022
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
(clinicaltrials.gov)
- P1 | N=104 | Recruiting | Sponsor: Sciwind Biosciences USA Co., Ltd.
New P1 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
1 to 4
Of
4
Go to page
1